CAZZAGON, NORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.848
AS - Asia 2.131
EU - Europa 1.921
SA - Sud America 545
AF - Africa 496
OC - Oceania 69
Continente sconosciuto - Info sul continente non disponibili 26
Totale 11.036
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.558
SG - Singapore 795
IT - Italia 493
HK - Hong Kong 378
BR - Brasile 333
CN - Cina 321
DE - Germania 188
PL - Polonia 137
FI - Finlandia 113
GB - Regno Unito 97
RU - Federazione Russa 97
NL - Olanda 92
FR - Francia 90
VN - Vietnam 73
SE - Svezia 66
AT - Austria 49
TR - Turchia 49
ES - Italia 43
IN - India 40
MX - Messico 38
UA - Ucraina 38
AR - Argentina 36
IE - Irlanda 35
JP - Giappone 35
IQ - Iraq 34
KR - Corea 32
EC - Ecuador 30
AU - Australia 28
RS - Serbia 27
UY - Uruguay 27
DK - Danimarca 24
NO - Norvegia 24
ZA - Sudafrica 24
CI - Costa d'Avorio 22
CO - Colombia 22
DZ - Algeria 22
BZ - Belize 21
CA - Canada 21
CY - Cipro 20
EE - Estonia 20
EG - Egitto 20
PY - Paraguay 20
RO - Romania 20
VE - Venezuela 20
AE - Emirati Arabi Uniti 19
ID - Indonesia 18
BA - Bosnia-Erzegovina 17
CG - Congo 17
CL - Cile 17
ET - Etiopia 17
HU - Ungheria 17
IL - Israele 17
IS - Islanda 17
LV - Lettonia 17
PA - Panama 17
TN - Tunisia 17
DJ - Gibuti 16
GR - Grecia 16
LB - Libano 16
PE - Perù 16
UZ - Uzbekistan 16
AM - Armenia 15
AO - Angola 15
BG - Bulgaria 15
BS - Bahamas 15
BY - Bielorussia 15
CH - Svizzera 15
HN - Honduras 15
MR - Mauritania 15
SI - Slovenia 15
TT - Trinidad e Tobago 15
AF - Afghanistan, Repubblica islamica di 14
BD - Bangladesh 14
BF - Burkina Faso 14
BW - Botswana 14
CW - ???statistics.table.value.countryCode.CW??? 14
GT - Guatemala 14
JO - Giordania 14
KE - Kenya 14
MN - Mongolia 14
NP - Nepal 14
PH - Filippine 14
PK - Pakistan 14
SK - Slovacchia (Repubblica Slovacca) 14
AZ - Azerbaigian 13
BE - Belgio 13
CV - Capo Verde 13
CZ - Repubblica Ceca 13
GF - Guiana Francese 13
GN - Guinea 13
GP - Guadalupe 13
LC - Santa Lucia 13
MK - Macedonia 13
PR - Porto Rico 13
PS - Palestinian Territory 13
TJ - Tagikistan 13
BB - Barbados 12
MY - Malesia 12
MZ - Mozambico 12
NA - Namibia 12
Totale 10.495
Salva come PNG Salva come JPEG
Città #
Fairfield 919
Ashburn 586
Woodbridge 495
Singapore 487
Houston 400
Hong Kong 370
Chandler 363
Seattle 316
Cambridge 311
Ann Arbor 281
Wilmington 252
Boardman 129
Beijing 112
Padova 111
San Diego 111
Santa Clara 105
Bytom 99
Princeton 77
Medford 76
Jacksonville 63
Munich 63
Des Moines 59
Milan 55
Roxbury 49
Helsinki 37
Los Angeles 37
Rome 34
Amsterdam 33
Nanjing 33
São Paulo 33
London 31
New York 31
Turku 29
Dublin 28
Buffalo 27
Vienna 27
Ho Chi Minh City 26
Montevideo 25
Nuremberg 23
Abidjan 21
Hefei 21
Madrid 21
Belgrade 19
Redondo Beach 18
Cairo 16
Frankfurt am Main 16
Melbourne 16
Panama City 16
Reykjavik 16
Riga 16
Tokyo 16
Djibouti 15
Guangzhou 15
Istanbul 15
Johannesburg 15
Lappeenranta 15
Stockholm 15
Tashkent 15
Bologna 14
Boston 14
Dallas 14
Luanda 14
Nouakchott 14
Shanghai 14
Baghdad 13
Castries 13
Conakry 13
Daejeon 13
Dushanbe 13
Mexico City 13
Nairobi 13
Nassau 13
Paris 13
Ulan Bator 13
Warsaw 13
Addis Ababa 12
Amman 12
Cayenne 12
Oslo 12
Tallinn 12
Accra 11
Belize City 11
Bridgetown 11
Guayaquil 11
Kigali 11
Lima 11
Nicosia 11
Palermo 11
Praia 11
Quito 11
San Francisco 11
Verona 11
Antananarivo 10
Athens 10
Baku 10
Bucharest 10
Chicago 10
Dakar 10
Hanoi 10
Havana 10
Totale 7.159
Salva come PNG Salva come JPEG
Nome #
UNIGASTRO : Malattie dell' Apparato Digerente . Edizione 2022 - 2025 ( Versione Italiana ) Capitolo: Epatite autoimmune 361
Primary biliary cirrhosis: overlaps with other autoimmune disorders 224
Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis 201
Coronary flow reserve in patients with primary biliary cholangitis 182
Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload. 177
Extrahepatic autoimmunity in autoimmune liver disease 176
Thyroid Dysfunction in Primary Biliary Cholangitis: A Comparative Study at Two European Centers 175
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 175
Extrahepatic Malignancies in Primary Biliary Cirrhosis: A Comparative Study at Two European Centers. 171
Metabolic Syndrome Associated With Primary Biliary Cirrhosis. 169
The prognostic role of magnetic resonance imaging in Primary Sclerosing Cholangitis 161
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study 159
The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis. 158
Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis 156
PERFORMANCE OF SURROGATE MARKERS OF HEPATIC FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 149
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 149
A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. 148
Morning bright light treatment for sleep-wake disturbances in primary biliary cholangitis: A pilot study 143
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 142
P.16.3 THE PROGNOSTIC ROLE OF MAGNETIC RESONANCE CHOLANGIOGRAPHY IN PSC 140
A novel HER2-targeted liposomal formulation for reducing the risk of liposome-induced hepatotoxicity 139
PERFORMANCE OF SURROGATE MARKERS OF HEPATIC FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 139
Diagnostic and Prognostic Role of Scca-IgM Serum Levels in Hepatocellular Carcinoma (Hcc). 137
New therapies for primary biliary cirrhosis 134
Extrahepatic Autoimmune Conditions Associated with Primary Biliary Cirrhosis. 133
Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. 131
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis 130
Molecular targeted therapy in hepatocellular carcinoma: present achievements and future challenges. 129
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 129
Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres. 128
Retreatment of patients with chronic hepatitis C relapsers to a previous antiviral treatment. 128
P.1.158: PEG-INTERFERON ALPHA-2A WITH WEIGHT-BASED RIBAVIRIN DOSES IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES: A PILOT STUDY IN A SINGLE CENTRE 126
The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis 126
New Organ-Specific Drug Strategies Interfering in Signaling Pathways: Kinase Inhibitors and Other New Developmental Drugs in HCC 126
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis 124
Easl Clinical Practice Guidelines (Cpgs) On Non-Invasive Tests For Evaluation Of Liver Disease Severity And Prognosis- 2020 Update 124
PERFORMANCE OF TRANSIENT ELASTOGRAPHY AND NON INVASIVE MARKERS OF LIVER FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 123
PERFORMANCE OF TRANSIENT ELASTOGRAPHY AND NON INVASIVE MARKERS OF LIVER FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 118
Pregnancy and Primary Biliary Cirrhosis: A Case-Control Study 117
Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis 117
Incidence and risk factors for extra-hepatic malignancies in primary biliary cirrhosis: A comparative study from two European referral centers 114
Sleep-wake profiles in patients with primary biliary cirrhosis 114
Female patients in fertile age with chronic hepatitis C, easy genotype, and persistently normal transaminases have a 100% chance to reach a sustained virological response. 111
Predictive criteria of response to endoscopic treatment for severe strictures in primary sclerosing cholangitis 111
Hepatic Stem/Progenitor Cell Activation Differs between Primary Sclerosing and Primary Biliary Cholangitis 110
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 108
A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis 106
Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from 20-year multicentre experience in Italy 104
INCIDENCE AND RISK FACTORS FOR EXTRA-HEPATIC MALIGNANCIES (EM) IN PRIMARY BILIARY CIRRHOSIS: A COMPARATIVE STUDY FROM TWO EUROPEAN REFERRAL CENTERS 104
METABOLIC SYNDROME INDUCES A MORE RAPID PROGRESSION OF FIBROSIS IN PRIMARY BILIARY CIRRHOSIS IN EARLY STAGE 102
PBC and related extrahepatic diseases 102
In-Hospital Screening Campaign Against Hepatitis C Could Be Effective for Identifying More Patients Who Still Need Treatment 99
Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study 99
Hepatitis B virus-related hepatocellular carcinoma: primary, secondary, and tertiary prevention. 98
Primary biliary cholangitis: Perception and expectation of illness in Italian patients 98
Pathology of non-alcoholic fatty liver disease 97
Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options 95
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis 95
null 93
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? 90
Proposed therapies in primary biliary cholangitis 89
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach 89
Pathology of autoimmune hepatitis 89
DIAGNOSTIC AND PROGNOSTIC ROLE OF SCCA-IgM IN HEPATOCELLULAR CARCINOMA (HCC) 86
Recommendations on the use of magnetic resonance imaging for collaborative multicenter studies in PSC 84
Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival 83
Gene expression profile in intrahepatic cholestasis of pregnancy. 82
Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis 81
Primary biliary cholangitis: treatment 80
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis 76
Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitis 75
Pregnancy and primary biliary cirrhosis: A case–control study 74
The phenolic compounds tyrosol and hydroxytyrosol counteract liver fibrogenesis via the transcriptional modulation of NADPH oxidases and oxidative stress-related miRNAs 73
Letter: the use of magnetic resonance scores (Anali) for risk stratification in PSC 73
Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitis 72
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 71
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 71
Rate of Spleen Length Progression Is a Marker of Outcome in Patients With Primary Sclerosing Cholangitis 69
Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury 69
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 68
Validation, clinical utility and limitations of the Amsterdam-Oxford model for primary sclerosing cholangitis 67
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 66
Primary Sclerosing Cholangitis: Diagnostic Criteria 66
Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data 65
UNIGASTRO: Digestive Diseases. 2022 - 2025 Edition (English Version) Chapter: Autoimmune Hepatitis 64
Gene expression profile in intrahepatic cholestasis of pregnancy. 58
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe 57
Primary sclerosing cholangitis and inflammatory bowel disease: a complicated yet unique relationship 56
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool 56
Impact on follow-up strategies in patients with primary sclerosing cholangitis 55
Patient-reported quality of care in primary sclerosing cholangitis 54
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival 54
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 53
The unhealthy lifestyle in primary biliary cholangitis: An enemy to fight 53
Reply to: Correspondence on "EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update" 53
Non-contrast MR lymphography of the lymphatic system of the liver 51
Liver Immunology, Principles and Practice, Third Edition Chapter 24: Primary Biliary Cholangitis: Autoimmune Hepatitis Overlap Syndrome 50
Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH Group 50
Pregnancy and Diseases of the Biliary Tree 49
Greater Transplant-free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls 49
Totale 10.804
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.367
article - articoli 37.809
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.871
Totale 80.047
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.005 0 0 168 161 58 33 31 123 122 150 122 37
2021/20221.246 85 82 163 57 69 141 80 96 94 56 87 236
2022/2023895 149 80 13 96 102 153 47 65 102 3 78 7
2023/2024743 25 61 46 54 64 92 123 50 39 35 65 89
2024/20252.605 20 207 101 80 229 85 117 231 276 145 489 625
2025/20262.741 524 724 1.493 0 0 0 0 0 0 0 0 0
Totale 11.233